Filing Details

Accession Number:
0001127602-20-022089
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-07-24 16:24:54
Reporting Period:
2020-07-23
Accepted Time:
2020-07-24 16:24:54
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1145197 Insulet Corp PODD Surgical & Medical Instruments & Apparatus (3841) 043523891
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1731734 Eric Benjamin C/o Insulet Corporation
100 Nagog Park
Acton MA 01720
Svp, Innovation And Strategy No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2020-07-23 6,520 $210.00 8,704 No 4 S Direct
Common Stock Acquisiton 2020-07-23 1,396 $30.02 10,100 No 4 M Direct
Common Stock Acquisiton 2020-07-23 6,996 $29.26 17,096 No 4 M Direct
Common Stock Disposition 2020-07-23 8,392 $210.00 8,704 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option (Right to Buy) Disposition 2020-07-23 1,396 $0.00 1,396 $30.02
Common Stock Employee Stock Option (Right to Buy) Disposition 2020-07-23 6,996 $0.00 6,996 $29.26
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2025-07-01 No 4 M Direct
0 2026-02-24 No 4 M Direct
Footnotes
  1. The transactions reported in this Form 4 were effected pursuant to an existing Rule 10b5-1 trading plan.
  2. Includes 107 shares acquired under the Insulet Corporation Stock Purchase Plan on May 29, 2020.
  3. This option is subject to a four-year vesting period, with 25% of the total award vesting one year after the grant date and the remainder vesting in equal quarterly installments each quarter thereafter for 12 quarters, subject to continued employment.
  4. This option is subject to a four-year vesting period with 25% of the total award vesting one year after the grant date and the remainder vesting in equal quarterly installments each quarter thereafter for 12 quarters, subject to continued employment.